Biofermin Pharmaceutical Co. Ltd. | |
Stock Exchange | Tokyo Stock Exchange |
EPS |
JPY192.6 |
Market Cap |
JPY27.43 B |
Shares Outstanding |
12.15 M |
Public Float |
3.84 M |
Address |
Sannomiya Central Building, 12/F Kobe Hyogo 650 Japan |
Employees | - |
Website | http://www.biofermin.co.jp |
Updated | 07/08/2019 |
Biofermin Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products, quasi-drugs, veterinary drugs, agrichemicals, cosmetics, medical equipment, foods, beverages, food additives, feeds, feed additives and other chemicals. Its products include pharmaceutical items such as New Biofermin S, Biofermin Antidiarrheal, Biofermin, Stomachic Tablets, Biofermin VC, Biofermin Laxatives, Biofermin R, etc. It also provides various clinical test services. |